Evidence map›Paper›PMID 34341685›Full record

ArticleAnnals of medicine and surgery (2012)2021

Covid-19 decompensating epilepsy in the elderly: A case report.

L Musoni, H Ezzouine, O Etouki, R Habibou, M Nour, I ElKhaouri, B Charra

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Annals of medicine and surgery (2012), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

L MusoniFaculty of Medicine and Pharmacy, Hassan II University of Casablanca, Morocco.
H EzzouineFaculty of Medicine and Pharmacy, Hassan II University of Casablanca, Morocco.
O EtoukiFaculty of Medicine and Pharmacy, Hassan II University of Casablanca, Morocco.
R HabibouFaculty of Medicine and Pharmacy, Hassan II University of Casablanca, Morocco.
M NourFaculty of Medicine and Pharmacy, Hassan II University of Casablanca, Morocco.
I ElKhaouriFaculty of Medicine and Pharmacy, Hassan II University of Casablanca, Morocco.
B CharraFaculty of Medicine and Pharmacy, Hassan II University of Casablanca, Morocco.
University of Hassan II Casablanca · MACentre Hospitalier Universitaire Ibn Rochd · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic has had a great impact on chronic diseases, including epilepsy. The imbalance of antiepileptic drugs in case of intercurrent infection with COVID-19 leads to worsening seizures. A 71-year-old man, followed for post-traumatic epilepsy for 30 years, was stabilized with phenobarbital and topiramate. He presented generalized tonic-clonic epileptic seizures without meningitis. He improved well on midazolam combined with the usual treatment before the diagnosis and worsening of the covid-19. The severity of the lung damage led to hypoxia, recurrence of seizures, and poor prognosis. The association between covid-19 and epilepsy remains pejorative despite management. An epileptic seizure should always be considered as a possible manifestation of COVID-19. The article aimed to establish the relationship between covid-19 and the risk of worsening seizures and to demonstrate the severity of the association between covid-19 and epilepsy in elderly patients.

Indexed as

Case reportCovid-19COVID-19, Coronavirus Disease 2019DecompensationElderly patientEpilepsyGCS, Glasgow Coma ScaleIl 6, Interleukine 6RT-PCR, Reverse Transcriptase-Polymerase Chain ReactionSCARE, surgical case reports

Identifiers

PMID34341685
PMCPMC8320423
OpenAlexW3185164060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.